Brent Michaels, DO
Dermatology · Las Vegas, NVNPI 1871749648
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 325 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 27.8% of the total. Reporting peaked in 2023 at $1,079 and has fallen 71.6% since, to $307 in 2025.
Across 325 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$580
- Pfizer$489
- Novartis$476
- E.r. Squibb & Sons, L.L.C.$359
- LEO Pharma Inc.$281
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,00794%
- Education$3386%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 91 | $1,487 |
| Johnson & Johnson | 16 | $580 |
| Pfizer | 25 | $489 |
| Novartis | 20 | $476 |
| E.r. Squibb & Sons, L.L.C. | 75 | $359 |
| LEO Pharma Inc. | 14 | $281 |
| Sun Pharmaceutical Industries Inc. | 12 | $246 |
| UCB, Inc. | 9 | $189 |
| Mayne Pharma Commercial LLC | 9 | $164 |
| Regeneron Healthcare Solutions, Inc. | 6 | $161 |
| Amgen | 8 | $155 |
| Sanofi | 6 | $111 |
| Galderma Laboratories, L.p. | 3 | $71 |
| Incyte Corporation | 4 | $69 |
| Almirall LLC | 4 | $66 |
| Biofrontera Inc. | 3 | $55 |
| Bristol Myers Squibb | 3 | $55 |
| Lilly USA, LLC | 3 | $54 |
| Boehringer Ingelheim | 2 | $53 |
| Merz North America, Inc. | 1 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| VYNE Pharmaceuticals Inc. | 1 | $26 |
| Genentech USA, Inc. | 2 | $26 |
| Merck | 2 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
| Strata Skin Sciences, Inc. | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $11 |
How this compares
$5,345 in reported general payments places this provider in the 55th percentile of 78 dermatology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 15 | $108,437 |
| Dupixent PenDupilumab | 15 | $54,488 |
| Fluorouracil | 35 | $2,605 |
| Fluocinonide | 62 | $2,155 |
| Mupirocin | 303 | $1,870 |
| Betamethasone Dipropionate | 34 | $1,706 |
| Triamcinolone Acetonide | 167 | $1,688 |
| Metronidazole | 26 | $1,620 |
| Doxycycline Hyclate | 137 | $1,580 |
| Clindamycin Phosphate | 46 | $1,466 |
| Ketoconazole | 81 | $1,257 |
| Erythromycin-Benzoyl PeroxideErythromycin/Benzoyl Peroxide | 11 | $737 |
| Ciclopirox | 29 | $737 |
| Cephalexin | 149 | $605 |
| Imiquimod | 27 | $589 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Las Vegas
- David CotterLas Vegas$1.4M
- Harry GreenbergLas Vegas$1.1M
- Miriam BettencourtLas Vegas$772K
- Victoria FarleyLas Vegas$151K
- Linda WoodsonLas Vegas$22K
- Candace SpannLas Vegas$18K
- Clifton HallLas Vegas$16K
- Jason StevensLas Vegas$15K
- Lionel HandlerLas Vegas$14K
- Frank RuecklLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.